Cytokines in osteoarthritis: Mediators or markers of joint destruction?

Seminars in Arthritis and Rheumatism

Volumn 25, Issue 4, 1996, Pages 254-272

  Westacott, C I ^a   Sharif, M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; JOINT DESTRUCTION; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW;

EID: 0029981825     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(96)80036-9     Document Type: Article

References (140)

1. Brandt K. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis, biochemical, immunological and clinicopathologic barriers J Rheumatol 16 suppl 18 1989 39 42
2. Stockwell R.A. Cartilage failure in osteoarthritis: Relevance of normal structure and function: A review Clin An at 1990 1993 161 191
3. Cooke T.D. Dwosh I.L. Clinical features of osteoarthritis in the elderly Clin Rheum Dis 12 1986 155 172
4. Arend W.P. Dayer J.-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum 33 1990 305 315
5. chap 2 Fenner H. Dayer J.-M. Hasler F. Anti-cytokines in rheumatoid arthritis: A novel strategy for therapeutic intervention Dayer J.-M. Cytokine Congress Reports: A Report of the 7th APLAR Congress of Rheumatology Bali, September 13-18, 1992 1993 RECOM Basel 19 24
6. Nathan C. Sporn M. Cytokines in context J Cell Biol 113 1991 981 986
7. chap 13 Arend W.P. Dayer J.-M. Cytokines and growth factors Kelley W.N. Harris E.D. Ruddy S. Textbook of Rheumatology vol 1 1993 Saunders Philadelphia 227 247
8. 2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes Ann NY Acad Sci 557 1989 46 59
9. Fiorentino D.F. Zlotnik A. Mosmann T.R. IL-10 inhibits cytokine production by activated macrophages J Immunol 11 1993 3815 3822
10. de Waal Malefyt R. Abrams J. Bennett B. Interleukin-10 inhibits Cyokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1991 1209 1230
11. Fenton M.J. Buras J.A. Donnelly R.P. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes J Immunol 149 1992 1283 1288
12. Suzuki H. Kamimura J. Ayabe T. Demonstration of neutralising autoantibodies against IL-1α in sera from patients with rheumatoid arthritis J Immunol 145 1990 2140 2146
13. Symons J.A. Eastgate J.A. Duff G.W. Purification and characterisation of a novel soluble receptor for interleukin-1 J Exp Med 174 1991 1251 1254
14. Brockhaus M. Schoenfeld H.-J. Schlaeger E.-J. Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies Proc Natl Acad Sci USA 87 1990 3127 3131
15. Baxter R.C. Circulating binding proteins for the insulin-like growth factors: Review Trends Endocrinol Metab 4 1993 91
16. Harvey A.K. Hrubey P.S. Chandrasekhar S. Transforming growth factor-beta inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptors on chondrocytes Exp Cell Res 195 1991 376 385
17. Tyler J.A. Insulin-like growth factor-1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to Cytokines Biochem J 260 1989 543 548
18. Mankin H.J. Dorfman H.D. Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. 11. Correlation of morphology with metabolic data J Bone Joint Surg 53A 1971 523
19. Mankin H.J. Brandt K.D. Biochemistry and metabolism of cartilage in osteoarthritis Moskowitz R.W. Osteoarthritis: Diagnosis and Medical/Surgical management 1992 Saunders Philadelphia, PA 109 154
20. Dayer J.-M. Fenner H. The role of Cytokines and their inhibitors in arthritis Baillieres Clin Rheumatol 6 1992 485 516
21. Brennan F.M. Chantry D. Jackson A. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis Lancet ii 1989 244 247
22. Rickard D.J. Gowen M. Cytokines in Arthritis ed 24 1993 Arthritis and Rheumatism Council Chesterfield, Derbyshire, UK
23. Pelletier J.-P. Roughley P.J. DiBattista J.A. Are Cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum 20 suppl 2 1991 12 25
24. Eastgate J.A. Symons J.A. Wood N.C. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis Lancet ii 1988 706 709
25. Nouri A.M.E. Panayi G.S. Goodman S.M. Cytokines and the chronic inflammation of rheumatic disease. 1. The presence of interleukin-1 in synovial fluids Clin Exp Immunol 55 1984 295 302
26. Wood D.D. Ihrie E.J. Dinarello C.A. Isolation of an interleukin-1-like factor from human joint effusions Arthritis Rheum 26 1983 975 983
27. Hopkins S.J. Humphreys M. Jayson M.I.V. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1 Clin Exp Immunol 72 1988 422 427
28. Westacott C.I. Whicher J.T. Barnes I.C. Synovial fluid concentration of five different Cytokines in rheumatic diseases Ann Rheum Dis 49 1990 676 681
29. Holt I. Cooper R.G. Denton J. Cytokine inter-relationships and their association with disease activity in arthritis Br J Rheum 31 1992 725 733
30. Westacott C.I. Taylor G. Atkins R.M. Interleukin-1α and β production by cells isolated from membrane around aseptically loose total joint replacements Ann Rheum Dis 51 1992 638 642
31. Al Saffar N. Revell P.A. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: Potential role in osteolysis Br J Rheumatol 33 1994 309 316
32. Martel-Pelletier J. McCollum R. DiBattista J. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes Arthritis Rheum 35 1992 530 540
33. Warnock M.G. Sharif M. Elson C.J. IL-1 β at physiological concentration stimulates degradation of human articular cartilage Bone and Mineral 25 suppl 1 1994 S36
34. Ismaiel S. Atkins R.M. Pearse M.F. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli Br J Rheum 31 1992 369 373
35. Koch A.E. Kunkel S.L. Chensue S.W. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages Clin Immunol Immunopathol 65 1992 23 29
36. Malyak M. Swaney R.E. Arend W.P. Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: Potential contribution from synovial fluid neutrophils Arthritis Rheum 36 1993 781 789
37. Firestein G.S. Boyle D.L. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis Arthritis Rheum 37 1994 644 652
38. Smith R.J. Chin J.E. Sam L.M. Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion. and chondrocyte responsiveness Arthritis Rheum 34 1991 78 83
39. Dieppe P. Cushnaghan J. Young P. Prediction of progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy Ann Rheum Dis 52 1993 557 563
40. Sokoloff L. Microcracks in the calcified layer of articular cartilage Arch Pathol Lab Med 117 1993 191 195
41. Brandt K.D. Mankin H.J. Pathogenesis of osteoarthritis Kelley W.M. Harris E.D. Ruddy S. Textbook of Rheumatology 1993 Saunders Philadelphia, PA 1355 1373
42. Campbell I.K. Piccolo D.S. Roberts M.J. Effects of tumour necrosis factor-alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes Arthritis Rheum 33 1990 542 552
43. (suppl) Brennan F.M. Chantry D. Jackson A.M. Cytokine production in culture by cells isolated from synovial membrane J Autoimmun 2 1992 177 186
44. Martel-Pelletier J. Cloutier J.M. Pelletier J.P. Cytokines, interleukin-1 and the tumour necrosis factor in human osteoarthritic tissue Trans Orthop Res Soc 15 1990 111
45. Hopkins S.J. Meager A. Cytokines in synovial fluid. 11. The presence of tumour necrosis factor and interferon Clin Exp Immunol 73 1988 88 92
46. di Giovine F.S. Nuki G. Duff G.W. Tumour necrosis factor in synovial exudates Ann Rheum Dis 47 1988 768 772
47. Venn G. Nietfeld J.J. Duits A.J. Elevated synovial fluid levels of interleukin-6 and tumour necrosis factor associated with early experimental canine osteoarthritis Arthritis Rheum 36 1993 819 826
48. Zangerle P.F. DeGroote D. Lopez M. Direct stimulation of cytokines (IL-1 β, TNFα, IL-6, IFNγ and GM-CSF) in whole blood. 11. Application to rheumatoid arthritis andosteoarthritis Cytokine 4 1992 568 575
49. Miller V.E. Rogers K. Muirden K.D. Detection of tumour necrosis factor alpha and interleukin-1 in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemicalmethods Rheumatol Int 13 1993 77 82
50. Westacott C.I. Atkins R.M. Dieppe P.A. Tumour necrosis factor-α receptor expression on chondrocytes isolated from human articular cartilage J Rheumatol 21 1994 1710 1715
51. Tartaglia L.A. Goeddel D.V. Two tumour necrosis factor receptors Immunol Today 13 1992 151 153
52. Westacott C.I. Ismaiel S. Atkins R.M. Human articular cartilage degradation and chondrocyte expression of TNF receptors Trans Orthop Res Soc 8 1993 739
53. Ding A.H. Porteau F. Regulation of tumour necrosis factor receptors on phagocytes (43454A) Soc Exp Biol Med 200 1992 458 465
54. Cope A.P. Aderka D. Doherty M. Increased levels of soluble tumour necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases Arthritis Rheum 35 1992 1160 1169
55. Lotz M. Guerne P.A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1 /EPA) J Biol Chem 266 1991 2017 2020
56. Nietfeld J.J. Wilbrink B. Helle M. Interleukin-1 induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage Arthritis Rheum 33 1990 1695 1701
57. Van Bladel S. Libert C. Fiers W. Interleukin-6 enhances the expression of tumour necrosis factor receptors on hepatoma cells and hepatocytes Cytokine 3 1991 149 154
58. Hamilton J.A. Waring P.M. Filonzi E.L. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and TNF-alpha J Immunol 150 1993 1496 1502
59. Campbell I.K. Waring P. Novak U. Production of leukaemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumour necrosis factor-alpha Arthritis Rheum 36 1993 790 794
60. Henrotin Y. Labasse A. Deby G. Production and actions of LIF on human articular chondrocytes Clin Rheumatol 12 1994 552
61. Carroll G.J. Bell M.C. Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage Rheumatol Int 13 1993 5 8
62. Lecron J.C. Roblot P. Chevalier S. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: Independent regulation of LIF and IL-6 under corticosteroid therapy Clin Exp Immunol 92 1993 23 26
63. Osborne K.D. Trippel S.B. Mankin H.J. Growth factor stimulation of adult articular cartilage J Orthop Res 7 1989 35 42
64. McQuillan D.J. Handley C.J. Robinson H.C. Control of proteoglycan synthesis Biochem J 237 1986 741 747
65. McQuillan D.J. Handley C.J. Campbell M.A. Stimulation of proteoglycan synthesis by serum and IGF-1 in cultured bovine articular cartilage Biochem J 240 1986 423 430
66. Moskowitz R.W. Boja B. Denko C.W. The role of growth factors in degenerative joint disorders J Rheumatol 18 suppl 27 1991 147 148
67. Melnyk V.O. Shipley G.D. Sternfield M.D. Synoviocytes synthesis bind and respond to basic fibroblast growth factor Arthritis Rheum 33 1990 493 500
68. Mankin H.J. Jennings L.C. Treadwell B.V. Growth factors and articular cartilage J Rheumatol 18 1991 636 647
69. Denko C.W. Boja B. Moskowitz R.W. Growth promoting peptides in osteoarthritis: Insulin, IGF-1, growth hormone J Rheumatol 17 1990 1217 1221
70. Denko C.W. Boja B. Growth factors in asymptomatic osteoarthritis: Insulin, insulin-like growth factor-1, growth hormone Immunopharmacology 2 1993 71 76
71. Middleton J.F.S. Tyler J.A. Upregulation of IGF-I gene expression in the lesions of osteoarthritic human cartilage Ann Rheum Dis 51 1992 440 447
72. Lee Y.L. Hintz R.L. James P.M. Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEPG2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-1 and IGF-II receptors Mol Endocrinol 2 1988 404 411
73. Schalkwijk J. Joosten L.A.B. Van den Berg W.B. Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid Arthritis Rheum 32 1989 66 71
74. Hughes C.E. Caterson B. White R.J. Monoclonal antibodies recognising protease-generated neoepitopes from cartilage proteoglycan degradation J Biol Chem 267 1992 16011 16014
75. George E. Sharif M. Dieppe P. Insulin-like growth factor-1 and biomechanical markers of osteoarthritis Br J Rheumatol 32 1993 265 268
76. Wuster C. Blum W.F. Schlemilch S. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis J Intern Med 234 1993 249 255
77. Schouten J.S.A.G. Van den Ouweland E.A. Valkenburg H.A. Insulin-like growth factor-1: Prognostic factor of knee osteoarthritis Br J Rheumatol 32 1993 274 280
78. Dore S. Pelletier J.-P. DeBattista J.A. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor-1 binding sites but are unresponsive to itsstimulation: Possible role of IGF-1 binding proteins Arthritis Rheum 37 1994 253 263
79. Elford P.R. Lamberts S.W.J. Contrasting modulation by transforming growth factor-beta-1 of insulin-like growth factor-1 production in osteoblasts and chondrocytes Endocrinology 127 1990 1635 1639
80. Wahl S.M. McCartney-Francis N. Mergenhagen S.E. Inflammatory and immunomodulatory role of TGFP Immunol Today 10 1989 258 261
81. Watanabe N. Rosenfield R.G. Hintz R.L. Characterisation of a specific insulin-like growth factor-1/ somatomedin-C receptor on high density, primary monolayer cultures of bovine articularchondrocytes: Regulation of receptor concentration by somatomedin, insulin and growth hormone J Endocrinol 107 1985 275 283
82. Villiger P.M. Lotz M. Differential expression of TGFP isoforms by human articular chondrocytes in response to growth factors J Cell Physiol 151 1992 318 325
83. Roberts A.B. Sporn M.B. Handbook of Experimental Pharmacology 1990 Springer-Verlag Berlin 419 472
84. Luyten F.P. Hascall V.C. Nissley S.P. Insulin-like growth factors maintain steady state metabolism of proteoglycans in bovine articular cartilage explants Arch Biochem Biophys 267 1988 416 425
85. Morales T.I. Roberts A.B. Transforming growth factor-β regulates the metabolism of proteoglycans in bovine cartilage organ cultures J Biol Chem 263 1988 12828 12831
86. Morales T.I. Transforming growth factor-β stimulates the synthesis of proteoglycan aggregates in calf articular cartilage organ cultures Arch Biochem Biophys 286 1991 99 106
87. Wahl S.M. Allen J.B. Wong H.L. Antagonistic and agonistic effects of transforming growth factor-β and IL-1 in rheumatoid synovium J Immunol 145 1990 2514 2519
88. Fava R. Olsen N. Keski-Oja J. Active and latent forms of transforming growth factor-β activity in synovial effusions J Exp Med 169 1989 291 296
89. Dubois C.M. Ruscetti F.W. Palaszynski E.W. Transforming growth factor-β is a potent inhibitor of interleukin-1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action J Exp Med 172 1990 737
90. Turner M.D. Chantry P. Katsikis A. Induction of interleukin receptor antagonist protein by transforming growth factor-β EJI 21 1991 1635 1639
91. Wahl S.M. Costa G.L. Corcoran M. Transforming growth factor-beta mediated IL-1-dependent induction of IL-1 receptor antagonist J Immunol 150 1993 3553 3560
92. Ashton I.K. Matheson J.A. Change in response with age of human articular cartilage to plasma somatomedin activity Calcif Tissue Int 29 1979 89 94
93. Recklies A.D. Roughley P.J. Bilimoria K.M. Differential response of young and old human articular chondrocytes to IGF-1 and TGFP Trans Orthop Res Soc 14 1989 281
94. Yamamoto H. Sohmiya M. Oka N. Effects of age and sex on plasma insulin-like growth factor (IGF-1) levels in normal adults Acta Endocrinol 124 1991 497 500
95. Saxne T. Heinegard D. Wollheim F.A. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis Lancet ii 1985 127 128
96. Saxne T. Heinegard D. Wollheim F.A. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease: Relation to systemic treatment Arthritis Rheum 30 1987 972 979
97. Saxne T. Heinegard D. Wollheim F.A. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid Ann Rheum Dis 45 1986 491 497
98. Heinegard H. Inerot S. Olsson S. Cartilage proteoglycans in degenerative joint disease J Rheumatol 14 1987 110 112
99. Heinegard D. Saxne T. Connective tissue macromolecules as markers for tissue processes in joint disease Eur J Rheumatol Inflamm 11 1991 91 99
100. William J.M. Downey C. Thonar E.-J.M.A. Increase in levels of serum keratan sulphate following cartilage proteoglycan degradation in rabbit knee-joint Arthritis Rheum 31 1988 557 560
101. Block J.A. Schnitzer T.J. Andersson G.B.J. The effects of chemonucleolysis on serum keratan sulphate levels in humans Arthritis Rheum 32 1989 100 104
102. Sweet M.B.E. Coehlo A. Schnitzler C.M. Serum keratan sulphate levels in osteoarthritis patients Arthritis Rheum 31 1988 648 652
103. Thonar E.-J.M.A. Lenz M.E. Klintworth G.K. Quantification of keratan sulphate in blood as a marker of cartilage catabolism Arthritis Rheum 28 1985 1367 1376
104. Spector T.D. Dacre J.E. Woodward L. Keratan sulphate as a marker of progression of knee OA Br J Rheumatol 30 1991 118
105. Sharif M. Saxne T. Shepstone L. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint Br J Rheumatol 34 1995 306 310
106. Creamer P. Sharif M. George E. Intracartilage hyaluronic acid in osteoarthritis of the knee: An investigation into mechanisms of action Osteoarthritis and Cartilage 2 1994 133 140
107. Sharif M. George E. Dieppe P.A. Correlation between a synovial fluid marker of cartilage and bone turnover and scintigraphic scan abnormality in osteoarthritis of the knee joint Arthritis Rheum 38 1995 78 81
108. Dodge G. Poole A.R. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilage and in explants of bovine articular cartilage cultured with interleukin-1 J Clin Invest 83 1989 647 661
109. Seibel M.J. Duncan A. Robins S.P. Urinary hydroxy pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases J Rheumatol 16 1989 969
110. Thompson P.W. Spector T.D. James I.T. Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis Br J Rheumatol 31 1992 759 761
111. Robins S.P. McLaren A.M. Nicol P. Pyridinium cross-link measurements in serum and synovial fluid of patients with osteoarthritis Kuettner K.E. Articular Cartilage and Osteoarthritis 1991 Raven Press New York, NY 738 739
112. Caterson B. Mahmoodian F. Sorrell J.M. Modulation of native chondroitin sulphate structure in tissue development and in disease J Cell Sci 97 1990 411 417
113. Poole A.R. Ionescu M. Swan A. Synovial fluid levels of two fragments of aggrecan in rheumatoid and osteoarthritis Arthritis Rheum 36 1993 S189
114. Slater R.R. Caterson B. Lachiewicz P. The occurrence of 3B3(-) and 7D4 epitopes as markers of arthritis in humans Trans Orthop Res Soc 17 1992 277
115. Heinegard D. Oldberg A. Structure and biology of cartilage and bone matrix non-collagenous macromolecules FASEB J 3 1989 2043 2051
116. Ostendorf R.H. Van Kampen G.P.J. 3B3(-) epitope expression induced by mechanical loading: An in vitro model for osteoarthritis Trans Orthop Res Soc 18 1993 710
117. Hazell P.K. Dent C. Fairclough J.A. Changes in chondroitin sulphate structures detected by monoclonal antibodies in synovial fluid following knee trauma Trans Orthop Res Soc 18 1993 711
118. Hinek A. Poole A.R. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin) J Bone Miner Res 3 1988 421 429
119. Yamaji T. Ito K. Hasegawa R. Sandwich enzyme immunoassay for chondrocalcin in serum Company report 1991 Teijin Ltd
120. Shinmei M. Ito K. Matsuyama S. Joint fluid carboxyl-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis Osteoarthritis and Cartilage 1 1993 121 128
121. Sabokbar A. Horton J.D. Bowler K. Raised levels of TNFα in cardiac transplant patients Clin Transplant 7 1993 459 466
122. Meager A. Gaines Das R.E. Immunological standardisation: International collaborative study of the candidate international standards for human tumour necrosis factors alpha(hTNFα) and beta (hTNFP) and for murine tumour necrosis factor alpha (mTNFo) J Immunol Med 170 1994 1 13
123. Cannon J.G. Nerad J.L. Poutsiaka D.D. Measuring circulating cytokines J Appl Physiol 75 1993 1897 1902
124. Chikanza I.C. Roux-Lombard P. Dayer J.-M. sTNF-R behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis Clin Exp Immunol 92 1993 19 22
125. di Padova F. Pozzi C. Tondre M.J. Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery Clin Exp Immunol 85 1991 137 142
126. McConkey B. Crockson R.A. Crockson A.P. Assessment of rheumatoid arthritis Q J Med 41 1972 115 125
127. Amos R.S. Constable T.J. Crockson R.A. Rheumatoid arthritis: Relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes Br Med J i 1977 195 197
128. van der Heijde D.M. van Riel P.L. van Rijswijk M.I.L. Influence of prognostic features on the final outcome in rheumatoid arthritis: A review of the literature Semin Arthritis Rheum 17 1988 284 292
129. Larsen A. The relationship of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis Scand J Rheumatol 17 1988 123 129
130. Pepys M.B. Rheumatoid arthritis: The role of acute phase proteins Br J Rheum 32 suppl 3 1993 1 2
131. Shine B. de Beer F.C. Pepys M.B. Solid phase radio-immunoassays for C-reactive protein Clin Chim Acta 117 1981 13 23
132. Loose L.D. de Oliveira R. Sipe J.D. A possible systemic component of osteoarthritis (OA): Elevated concentrations (by ELISA) of C-reactive protein (CRP) in serum of OA patients and modulation by Tenidap Arthritis Rheum 36 1993 S166
133. Carter D.R. Orr T.E. Fyhrie D.P. Influences of mechanical stress on prenatal and postnatal skeletal development Clin Orthop 219 1987 237 251
134. Dean D.D. Martel-Pelletier J. Pelletier J.-P. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage J Clin Invest 84 1989 678 685
135. Lohmander L.S. Roos H. Dahlberg L. Temporal patterns of stromelysin-1, tissue inhibitor and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus J Orthop Res 12 1994 21 28
136. Pelletier J.-P. Faure M.-P. DiBattista J.A. Co-ordinated synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis: A immunohistochemical study Am J Pathol 142 1993 95 105
137. Pickvance E.A. Oegema T.R. Jr Thompson R.C. Jr Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading J Orthop Res 11 1993 313 323
138. Simon S.R. Radin E.L. Paul I.L. The response of joints to impact loading. II. in vivo behaviour of subchondral bone J Biomech 5 1972 267 272
139. Sharif M. George E. Shepstone L. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee Arthritis Rheum 38 1995 760 767
140. Alwan W.H. Dieppe P.A. Elson C.J. Bone resorbing activity in synovial fluids in destructive and rheumatoid arthritis Ann Rheum Dis 47 1988 198 205